Table 1 Opioids-containing products used by respondents and distribution of demographic characteristics among opioids user and non-opioids users (n = 520)
Variable | Using opioids n (%) n = 146 | Not using opioids n (%) n = 374 | Chi-square | p-value |
|---|---|---|---|---|
Gender | ||||
Male | 73 (50.0) | 190 (50.8) | ||
Female | 73 (50.0) | 184 (49.2) | 0.027 | 0.869 |
Age (year) | ||||
16–20 | 43 (29.5) | 144 (38.5) | ||
≥ 20 | 103 (70.5) | 230 (61.5) | 3.735 | 0.053 |
Level of study | ||||
Year 1 | 5 (3.4) | 48 (12.8) | ||
Year 2 | 36 (24.7) | 101 (27.0) | ||
Year 3 | 55 (37.7) | 124 (33.2) | ||
Year 5 | 50 (34.2) | 101 (27.0) | 9.092 | 0.003* |
Faculty | ||||
Medicine and surgery | 89 (61.0) | 246 (65.8) | ||
Pharmacy | 57 (39.0) | 128 (34.2) | 1.063 | 0.303 |
Opioids-containing products used by respondents Ψ (n = 178) | n (%) | |||
Diphenhydramine+dextromethorphan (12.5 mg) with codeine cough syrup (Benylin®) | 91 (51.1) | |||
Ammonium chloride+diphenyhydramine (14 mg) with codeine (10.9 mg) cough syrup (Emzolyn®) | 66 (37.1) | |||
Paracetamol (500 mg) with codeine (8 mg) (Cocodamol®) | 8 (4.5) | |||
Dextromethorphan + diphenhydramine with codeine (9 mg) cough syrup (Myasedyl®) | 6 (3.4) | |||
Hydrocodone | 5 (2.8) | |||
Oxycodone | 2 (1.1) | |||